Internal Medicine, Infectious Disease · Suwanee, GA
NPI
1942258314
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
5400 Laurel Springs Pkwy Ste 1404
Suwanee, GA, 30024
Phone (678) 347-2153
Groups this clinician bills Medicare through
Medicare paid, 2024
$330K
13,679 services
Medicare patients, 2024
138
Average age 72
Drug cost, 2024
$617K
1,210 prescriptions
Company payments, 2025
$1,187
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew Pugliese was code 99489 (chronic, principal, and transitional care management), 829 times for 17 patients. In total Andrew Pugliese billed 13,679 services in 40 codes, and Medicare paid $330K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99489 Chronic, Principal, and Transitional Care Management | Office | 829 | 17 | $55.63 | $46K |
| 99213 Office E&M - Established | Office | 438 | 105 | $66.26 | $29K |
| 99214 Office E&M - Established | Office | 292 | 75 | $92.60 | $27K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 212 | 22 | $0.08 | $17.77 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 149 | 18 | $96.86 | $14K |
| 96372 Injection Administration | Office | 145 | 32 | $10.73 | $1,556 |
| 96365 Intravenous Infusion, Hydration | Office | 135 | 14 | $47.28 | $6,383 |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 119 | 17 | $9.07 | $1,079 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 112 | 11 | $0.31 | $35.08 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 44 | 20 | $0.94 | $41.2 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 28 | 20 | $11.86 | $332 |
| 99204 Office E&M - New | Office | 27 | 27 | $116.70 | $3,151 |
By year: 2022 $342K for 13,130 services; 2023 $343K for 11,740 services; 2024 $330K for 13,679 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 77 | 26 | $2.96 | $228 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew Pugliese prescribed most often to Medicare patients was Doxycycline Hyclate, with 86 prescriptions and refills. In total Andrew Pugliese wrote 1,210 Medicare prescriptions that cost $617K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 86 | 90 | 36 | $1,523 |
| Ertapenem Ertapenem Sodium | 55 | 55 | Under 11 | $46K |
| Fluconazole Generic | 53 | 61 | 18 | $637 |
| Cefdinir Generic | 46 | 46 | 23 | $866 |
| Sodium Chloride 0.9 % Sodium Chloride | 46 | 46 | Under 11 | $1,752 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 42 | 42 | 25 | $925 |
| Methylprednisolone Generic | 41 | 41 | 27 | $196 |
| Meropenem Generic | 33 | 33 | Under 11 | $4,131 |
| Valacyclovir Valacyclovir Hcl | 33 | 35 | 14 | $1,663 |
| Vancomycin Hcl Generic | 29 | 29 | Under 11 | $9,661 |
| Minocycline Hcl Generic | 28 | 38 | Under 11 | $375 |
| Montelukast Sodium Generic | 21 | 41 | Under 11 | $175 |
| Nystatin Generic | 20 | 22 | 11 | $501 |
| Micafungin Micafungin Sodium | 20 | 20 | Under 11 | $23K |
| Zolpidem Tartrate Generic | 19 | 27 | Under 11 | $78.13 |
Brand drugs: - claims; generic drugs: 1,020 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew Pugliese $1,187 ($1,187 in general payments such as food, travel and fees) from 15 companies. The largest payer was Pfizer Inc. with $220.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 15 | $220 |
| Paratek Pharmaceuticals, Inc. | 12 | $166 |
| ViiV Healthcare Company GSK | 5 | $128 |
| Gilead Sciences, Inc. GILD | 5 | $120 |
| Pharming Healthcare, Inc. | 5 | $105 |
| Cumberland Pharmaceuticals, Inc. CPIX | 5 | $102 |
| Napo Pharmaceuticals Inc | 4 | $91.19 |
| Melinta Therapeutics, LLC | 3 | $48.65 |
| Theratechnologies Inc. THTX | 3 | $47.87 |
| AngioDynamics, Inc. ANGO | 1 | $46.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.